The European Commission Initiatives on Breast and Colorectal Cancer (ECIBC and ECICC) main features include:
- These initiatives are based on the latest scientific evidence available and follow an international recognised methodology for their activities, which also provides for full transparency and traceability.
- The activities can rely on the support of national representatives from all around Europe.
- The working groups are multidisciplinary teams including health care professionals, researchers as well as patient advocates who participate in every phase of the discussion and development of both the guidelines and the quality assurance scheme.
- The initiatives pay particular attention on patients' needs during the entire care pathway in a comprehensive manner.
- The initiatives foresee the development of European breast and colorectal cancer guidelines on cancer (prevention) screening and diagnosis, and associated quality assurance schemes for healthcare services to facilitate the implementation of quality ensured screening and follow-up.
- The quality assurance schemes cover the entire cancer care pathway, from prevention and screening to diagnosis, treatment, rehabilitation, management of recurrence and palliative care.
- The European Commission supports the implementation of ECIBC and ECICC in interested countries on a voluntary basis.
- Possible conflicts of interests are managed through annual and specific declarations of interests.
- ECIBC was the first initiative of this type undertaken by the Commission and has served as a blueprint for the development of ECICC. The lessons learned in the development of these pioneering projects will influence the design of its subsequent activities.